Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Sutro Biopharma Inc buy Piper Sandler

Start price
€4.78
03.04.24 / 50%
Target price
€10.16
03.04.25
Performance (%)
-26.78%
Price
€3.58
06.05.24
Summary
This prediction is currently active. The prediction for Sutro Biopharma Inc disappoints with a performance of -26.78%. This prediction currently runs until 03.04.25. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Sutro Biopharma Inc 9.816% 9.816%
iShares Core DAX® 0.476% -0.039%
iShares Nasdaq 100 1.290% 0.504%
iShares Nikkei 225® 1.300% -2.135%
iShares S&P 500 0.829% 0.193%

Comments by Piper_Sandler for this prediction

In the thread Sutro Biopharma Inc diskutieren
Prediction Buy
Perf. (%) -26.78%
Target price 10.159
Change
Ends at 03.04.25

Sutro Biopharma, Inc. (NASDAQ: STRO) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $11.00 price target on the stock, down previously from $12.00.
Ratings data for STRO provided by MarketBeat

Stopped prediction by Piper_Sandler for Sutro Biopharma Inc

buy
Sutro Biopharma Inc

Start price
Target price
Perf. (%)
€2.28
15.11.23
€11.04
15.11.24
57.02%
06.05.24